Combination Product Groups Calls For New FDA Policy on IVDs, LDTs

The Food and Drug Administration (FDA) needs to take action and make a decision on whether it has the authority to regulate laboratory-developed tests (LDTs) as medical devices, a group representing manufacturers of combination products said in a recent letter to the agency. The Combination Products Coalition (CPC) May 15 told the FDA it needs…